Melanoma
📧 Sign up to get email alerts when something new happens for Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-11-26Clinical Trial Update: Hepatic Arterial Infusion of Nab-Paclitaxel in Patients With Metastatic Melanoma in the Liver [Phase 1]
This document reports the completion of a Phase 1 clinical trial evaluating hepatic arterial infusion of nab-paclitaxel in patients with mel…
-
CLINICAL_TRIALS trial_result · 2015-11-18Clinical Trial Update: A Study Investigating SGI-110 in Combination With Ipilimumab in Unresectable or Metastatic Melanoma Patients [Phase 1]
A Phase 1 trial evaluating the combination of guadecitabine (SGI-110) with ipilimumab in unresectable or metastatic melanoma; current status…
-
CLINICAL_TRIALS trial_result · 2015-11-03Clinical Trial Update: Carboplatin, Paclitaxel, and Temozolomide for Patients With Metastatic Melanoma [Phase 2]
Phase 2 trial evaluating a combination of carboplatin, paclitaxel, and temozolomide in metastatic melanoma has been terminated, with results…
-
CLINICAL_TRIALS trial_result · 2015-10-26Clinical Trial Update: Cell Therapy for Metastatic Melanoma Using CD8 Enriched Tumor Infiltrating Lymphocytes [Phase 1, Phase 2]
Phase 1/2 trial evaluating CD8-enriched tumor-infiltrating lymphocytes for metastatic melanoma. The study was terminated and results were po…
-
CLINICAL_TRIALS trial_result · 2015-10-19Clinical Trial Update: Phase II Safety Study of Vemurafenib Followed by Ipilimumab in Subjects With V600 BRAF Mutated Advanced Melanoma [Phase 2]
Phase II safety study evaluating vemurafenib followed by ipilimumab in subjects with V600 BRAF-mutated advanced melanoma completed, with res…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-10-14Clinical Trial Update: Interferon Alfa in Treating Patients With Stage IV Solid Tumors, Lymphoma, or Myeloma [Phase 1]
Phase 1 clinical trial update of Interferon alfa in patients with stage IV solid tumors, lymphoma, or multiple myeloma; the study status is …
-
CLINICAL_TRIALS trial_result · 2015-10-12Clinical Trial Update: Phase II, 2nd Line Melanoma - RAND Monotherapy [Phase 2]
Phase II trial evaluating RAND Monotherapy for second-line melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2015-10-07Clinical Trial Update: Nuclear and Near-Infrared (NIR) Imaging in Melanoma [Phase 1]
A Phase 1 clinical trial evaluating nuclear and near-infrared imaging for melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2015-10-07Clinical Trial Update: Safety and Efficacy Study of DCVax-Direct in Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 safety and efficacy study of DCVax-Direct in solid tumors is being conducted by Northwest Biotherapeutics. The current status of…
-
CLINICAL_TRIALS trial_result · 2015-10-06Clinical Trial Update: Anti-CD20 (Cluster of Differentiation Antigen 20) Therapy to Treat Metastatic Melanoma [Phase 2]
Phase 2 trial evaluating anti-CD20 therapy (rituximab) for metastatic melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2015-10-05Clinical Trial Update: A Pharmacokinetic Study of RO5185426 in Combination With a Drug Cocktail in Patients With Metastatic Melanoma [Phase 1]
Phase 1 pharmacokinetic study of RO5185426 in combination with a drug cocktail in patients with metastatic melanoma; results were posted in …
-
CLINICAL_TRIALS trial_result · 2015-10-02Clinical Trial Update: Interferon Beta in Treating Patients With Metastatic Cutaneous Melanoma or Ocular Melanoma [Phase 2]
A Phase 2 trial evaluating interferon beta in patients with metastatic cutaneous melanoma or ocular melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2015-10-02Clinical Trial Update: Study of Vaccination With Poly-ICLC and Peptide-pulsed Dendritic Cells [Phase 1]
A Phase 1 trial evaluated vaccination with Poly-ICLC and peptide-pulsed dendritic cells for melanoma. The study has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-10-02Clinical Trial Update: Melphalan and Whole-Body Hyperthermia in Treating Patients With Advanced Melanoma [Phase 2]
A Phase 2 trial evaluating melphalan with whole-body hyperthermia in patients with advanced melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2015-10-01Clinical Trial Update: Fludarabine Followed By Adoptive Immunotherapy in Treating Patients With Stage IV Melanoma [Phase 1]
This Phase 1 trial investigated fludarabine followed by adoptive immunotherapy in patients with stage IV melanoma and has completed.
-
CLINICAL_TRIALS trial_result · 2015-10-01Clinical Trial Update: Investigation of a Behavioral Substitute for Sunbathing [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial at University of Massachusetts investigating a behavioral substitute for sunbathing in melanoma/skin cancer…
-
CLINICAL_TRIALS trial_result · 2015-09-29Clinical Trial Update: A Study to Assess APO866 for the Treatment of Advanced Melanoma [Phase 2]
This update notes the completion of a Phase 2 study evaluating APO866 for advanced melanoma.
-
CLINICAL_TRIALS trial_result · 2015-09-28Clinical Trial Update: The Response of Serum 25-Hydroxyvitamin D to Incidental Ultraviolet Light Exposure
A completed clinical trial examined how incidental UV exposure affects serum 25-hydroxyvitamin D levels in melanoma patients.
-
CLINICAL_TRIALS trial_result · 2015-09-24Clinical Trial Update: Phase I Oncovir Poly IC:LC and NY-ESO-1/gp100 [Phase 1]
Phase I trial update of a combination therapy using Poly IC:LC and NY-ESO-1/gp100 vaccine in melanoma. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2015-09-11Clinical Trial Update: Safety and Efficacy Study of Electrotransfer of Plasmid AMEP to Treat Advanced or Metastatic Melanoma [Phase 1]
A Phase 1 safety and efficacy trial evaluating electrotransfer of the AMEP plasmid for advanced or metastatic melanoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-09-04Clinical Trial Update: An Extension Study Administering YM155 to Subjects Previously Enrolled in Another Protocol Administering YM155 [Phase 2]
Extension phase 2 study update for YM-155 in prostate cancer, melanoma, and non-Hodgkin lymphoma; status completed.
-
CLINICAL_TRIALS trial_result · 2015-09-04Clinical Trial Update: A Study of YM155 Plus Docetaxel in Subjects With Stage III (Unresectable) or Stage IV Melanoma [Phase 2]
This document reports the completion of a Phase 2 trial evaluating YM155 plus docetaxel in unresectable or metastatic melanoma.
-
CLINICAL_TRIALS trial_result · 2015-09-02Clinical Trial Update: Multicenter Selective Lymphadenectomy Trial (MSLT) [Phase 3]
Phase 3 multicenter trial evaluating selective lymphadenectomy in melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2015-08-27Clinical Trial Update: Efficacy of Bevacizumab Monotherapy in Treatment of Metastatic Melanoma [Phase 2]
Phase 2 trial assessing bevacizumab as a monotherapy for metastatic melanoma has completed and reported efficacy results.
-
CLINICAL_TRIALS trial_result · 2015-08-18Clinical Trial Update: T-cell Based Immunotherapy for of Melanoma [Phase 1, Phase 2]
This clinical trial update reports the Phase 1/2 evaluation of a T-cell–based immunotherapy for melanoma, with the study status listed as co…